Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 28

1.

Isonatric Dialysis Biofeedback in Hemodiafiltration with Online Regeneration of Ultrafiltrate in Hypertensive Hemodialysis Patients: A Randomized Controlled Study.

Chevalier L, Tielemans C, Debelle F, Vandervelde D, Fumeron C, Mandart L, Stolear JC, Simon I, Delmas Y, Testa A, Mat O, Tezenas du Montcel S, Mercadal L.

Blood Purif. 2016;41(1-3):87-93. doi: 10.1159/000441967. Epub 2015 Nov 19.

PMID:
26580275
2.

Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial.

Moe SM, Chertow GM, Parfrey PS, Kubo Y, Block GA, Correa-Rotter R, Drüeke TB, Herzog CA, London GM, Mahaffey KW, Wheeler DC, Stolina M, Dehmel B, Goodman WG, Floege J; Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial Investigators*..

Circulation. 2015 Jul 7;132(1):27-39. doi: 10.1161/CIRCULATIONAHA.114.013876. Epub 2015 Jun 9.

3.

The Effects of Cinacalcet in Older and Younger Patients on Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial.

Parfrey PS, Drüeke TB, Block GA, Correa-Rotter R, Floege J, Herzog CA, London GM, Mahaffey KW, Moe SM, Wheeler DC, Kubo Y, Dehmel B, Goodman WG, Chertow GM; Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial Investigators..

Clin J Am Soc Nephrol. 2015 May 7;10(5):791-9. doi: 10.2215/CJN.07730814. Epub 2015 Feb 20.

4.

Long-term follow-up of cyclophosphamide compared with azathioprine for initial maintenance therapy in ANCA-associated vasculitis.

Walsh M, Faurschou M, Berden A, Flossmann O, Bajema I, Hoglund P, Smith R, Szpirt W, Westman K, Pusey CD, Jayne DR; European Vasculitis Study Group..

Clin J Am Soc Nephrol. 2014 Sep 5;9(9):1571-6. doi: 10.2215/CJN.00100114. Epub 2014 Jun 26.

5.

Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis.

EVOLVE Trial Investigators., Chertow GM, Block GA, Correa-Rotter R, Drüeke TB, Floege J, Goodman WG, Herzog CA, Kubo Y, London GM, Mahaffey KW, Mix TC, Moe SM, Trotman ML, Wheeler DC, Parfrey PS.

N Engl J Med. 2012 Dec 27;367(26):2482-94. doi: 10.1056/NEJMoa1205624. Epub 2012 Nov 3.

6.

Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up.

Harper L, Morgan MD, Walsh M, Hoglund P, Westman K, Flossmann O, Tesar V, Vanhille P, de Groot K, Luqmani R, Flores-Suarez LF, Watts R, Pusey C, Bruchfeld A, Rasmussen N, Blockmans D, Savage CO, Jayne D; EUVAS investigators..

Ann Rheum Dis. 2012 Jun;71(6):955-60. doi: 10.1136/annrheumdis-2011-200477. Epub 2011 Nov 29.

PMID:
22128076
7.

Prognostic value of aortic stiffness and calcification for cardiovascular events and mortality in dialysis patients: outcome of the calcification outcome in renal disease (CORD) study.

Verbeke F, Van Biesen W, Honkanen E, Wikström B, Jensen PB, Krzesinski JM, Rasmussen M, Vanholder R, Rensma PL; CORD Study Investigators..

Clin J Am Soc Nephrol. 2011 Jan;6(1):153-9. doi: 10.2215/CJN.05120610. Epub 2010 Sep 9.

8.

Rapid, enhanced, and persistent protection of patients with renal insufficiency by AS02(V)-adjuvanted hepatitis B vaccine.

Surquin M, Tielemans CL, Kulcsár I, Ryba M, Vörös P, Mat O, Treille S, Dhaene M, Stolear JC, Kuriyakose SO, Leyssen MX, Houard SA.

Kidney Int. 2010 Feb;77(3):247-55. doi: 10.1038/ki.2009.454. Epub 2009 Nov 25.

9.

Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial.

de Groot K, Harper L, Jayne DR, Flores Suarez LF, Gregorini G, Gross WL, Luqmani R, Pusey CD, Rasmussen N, Sinico RA, Tesar V, Vanhille P, Westman K, Savage CO; EUVAS (European Vasculitis Study Group)..

Ann Intern Med. 2009 May 19;150(10):670-80.

PMID:
19451574
10.

Lanthanum carbonate treatment, for up to 6 years, is not associated with adverse effects on the liver in patients with chronic kidney disease Stage 5 receiving hemodialysis.

Hutchison AJ, Barnett ME, Krause R, J, Siami GA; Lanthanum Carbonate Study Group..

Clin Nephrol. 2009 Mar;71(3):286-95.

PMID:
19281739
11.

Abdominal aortic calcification in dialysis patients: results of the CORD study.

Honkanen E, Kauppila L, Wikström B, Rensma PL, Krzesinski JM, Aasarod K, Verbeke F, Jensen PB, Mattelaer P, Volck B; CORD study group..

Nephrol Dial Transplant. 2008 Dec;23(12):4009-15. doi: 10.1093/ndt/gfn403. Epub 2008 Aug 1.

12.

Switching to lanthanum carbonate monotherapy provides effective phosphate control with a low tablet burden.

Hutchison AJ, Laville M; SPD405-313 Lanthanum Study Group..

Nephrol Dial Transplant. 2008 Nov;23(11):3677-84. doi: 10.1093/ndt/gfn310. Epub 2008 Jun 24.

13.

Lipid and apoprotein changes during atorvastatin up-titration in hemodialysis patients with hypercholesterolemia: a placebo-controlled study.

Lins RL, Matthys KE, Billiouw JM, Dratwa M, Dupont P, Lameire NH, Peeters PC, Stolear JC, Tielemans C, Maes B, Verpooten GA, Ducobu J, Carpentier YA.

Clin Nephrol. 2004 Oct;62(4):287-94.

PMID:
15524059
14.

Renal impairment in patients with inflammatory bowel disease: association with aminosalicylate therapy?

Elseviers MM, D'Haens G, Lerebours E, Plane C, Stolear JC, Riegler G, Capasso G, Van Outryve M, Mishevska-Mukaetova P, Djuranovic S, Pelckmans P, De Broe ME; 5-ASA Study Group..

Clin Nephrol. 2004 Feb;61(2):83-9.

PMID:
14989626
15.

Pharmacokinetics of atorvastatin and its metabolites after single and multiple dosing in hypercholesterolaemic haemodialysis patients.

Lins RL, Matthys KE, Verpooten GA, Peeters PC, Dratwa M, Stolear JC, Lameire NH.

Nephrol Dial Transplant. 2003 May;18(5):967-76.

PMID:
12686673
16.

Cardiac troponin T and malondialdehyde modified plasma lipids in haemodialysis patients.

Scott B, Deman A, Peeters P, Van den Branden C, Stolear JC, Van Camp G, Verbeelen D.

Nephrol Dial Transplant. 2003 Apr;18(4):737-42.

PMID:
12637643
17.

The predictive value of cardiac troponin T measurements in subjects on regular haemodialysis.

Stolear JC, Georges B, Shita A, Verbeelen D.

Nephrol Dial Transplant. 1999 Aug;14(8):1961-7.

PMID:
10462278
18.

5-Aminosalicylic acid (5-ASA) and chronic tubulointerstitial nephritis in patients with chronic inflammatory bowel disease: is there a link?

De Broe ME, Stolear JC, Nouwen EJ, Elseviers MM.

Nephrol Dial Transplant. 1997 Sep;12(9):1839-41. Review. No abstract available.

PMID:
9306332
19.
20.

Pharmacokinetics of linsidomine (SIN 1) after single and multiple intravenous short infusions in patients with renal insufficiency.

Sennesael J, Verbeelen D, Degré S, Unger P, Stolear JC, Ostrowski J, von Hattingberg HM, Gaertner W.

Int J Clin Pharmacol Ther Toxicol. 1993 Nov;31(11):533-41.

PMID:
8294165

Supplemental Content

Loading ...
Support Center